Naziv |
Akcije |
Margetić, Sandra; Bronić, Ana; Magdić Turković, Tihana; Tomić, Franciska; Ćelap, Ivana
Concentrations of direct oral anticoagulants acting as FXa inhibitors could not be accurately determined in patients treated with therapeutic doses of low molecular heparin as bridging therapy // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 458-459 doi: 10.1016/j.rpth.2023.100939 |
|
Margetić, Sandra; Ćelap, Ivana; Obuljen, Jasna; Leniček Krleža, Jasna; Linarić, Irena; Tomić, Franciska; Razum, Marija
Peak plasma concentrations of apixaban in children, adolescents and young adults with different dosing regimens applied // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 502-503 doi: 10.1016/j.rpth.2023.101004 |
|
Margetić, Sandra; Ćelap, Ivana; Razum, Marija, Tomić, Franciska; Šupraha-Goreta, Sandra
Presentation of Four Real-Life Patients with Persistently Low Both Peak and Trough Direct Oral Anticoagulant Levels in Plasma: Potential Effect of Drug-Drug Interactions // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 446-446 doi: 10.1016/j.rpth.2023.100951 |
|
Ćelap, Ivana; Margetić, Sandra; Mihić, Roman; Razum, Marija
Reporting of DOAC concentration as FXa inhibitory units: a possible solution for smaller laboratories // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 486-486 doi: 10.1016/j.rpth.2023.100979 |
|
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Vahtarić, Antonio; Josipović, Josipa; Gaćina, Petar
Evaluation of Proinflammatory and Haemostasis Markers after BNT162b2 SARS-CoV-2 Vaccination // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 408-409 doi: 10.1016/j.rpth.2023.100860 |
|
Ćelap, Ivana; Ivanko, Iva; Margetić, Sandra; Stojanović, Ivana
Combined DOAC and antiplatelet therapy caused menorrhagia in young woman - case report // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 460-461 doi: 10.1016/j.rpth.2023.100942 |
|
Grubić Rotkvić, Petra ; Ćelap, Ivana ; Bralić Lang, Valerija ; Jug, Juraj ; Snagić, Andrea ; Huljev Šipoš, Ivana ; Cigrovski Berković, Maja
Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt heart disease // Journal of diabetes and its complications, 37 (2023), 8; 108541, 10. doi: 10.1016/j.jdiacomp.2023.108541 |
|
Ćelap, Ivana; Margetić, Sandra; Džudović, Jelena; Razum, Marija
Comparison of rivaroxaban concentrations measured by anti-Xa rivaroxaban calibrated assay and LC-MS/MS // Research and practice in thrombosis and haemostasis, 7, Suppl 2. 2023. str. 467-467 doi: 10.1016/j.rpth.2023.100953 |
|
Fabijanec, Marija; Hulina Tomašković, Andrea; Rumora, Lada; Somborac Bačura, Anita; Čeri, Andrea; Ćelap, Ivana; Ljubičić, Neven; Baršić, Neven; Ramić, Snježana; Barišić, Karmela
Expression of microRNAs isolated from formalin-fixed paraffin-embedded tissue samples and exosomes of patients with colorectal carcinoma or adenoma // FEBS Open Bio, 13, Supplement. 2023. str. 90-90 doi: 10.1002/2211-5463.13646 |
|
Ivanko, Iva; Ćelap, Ivana; Margetić, Sandra; Marijančević, Domagoj; Josipović, Josipa; Gaćina, Petar
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination // Thrombosis research, 228 (2023), 8; 137-144. doi: 10.1016/j.thromres.2023.06.008 |
|